Home » Newsletters » BioWorld

BioWorld

Nov. 28, 2000

View Archived Issues

Appointments and Advancements

European Patent Disclosures

Other News To Note

Correction

Glaxo, Vertex Move Prodrug Into Phase III Studies For HIV

For Bubonic Plague's Wily YopJ Virulence Factor, Human Victims Merely Evolutionary Afterthought

NeuroSearch, Organon Target GABA Receptors In Collaboration

Insmed Tumbles 42 Percent On Preliminary INS-1 Results